Related Experiment Video
Updated: Jul 1, 2025

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
Factors associated to mortality in children with critical COVID-19 and multisystem inflammatory syndrome in a
Emmerson C F de Farias1,2, Manoel J C Pavão Junior3, Susan C D de Sales3
1Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, PA, Brazil. emmersonfariasbrandynew@gmail.com.
Insights
Critical COVID-19 and MIS-C in children in the Amazon region have high mortality rates. Factors like ARDS and thrombocytopenia are associated with death in critically ill pediatric patients.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- While SARS-CoV-2 is typically mild in children, critical forms like severe COVID-19 and MIS-C can occur.
- The Amazonian region presents unique challenges for healthcare access and outcomes.
Purpose of the Study:
- To describe the characteristics of critically ill children with COVID-19 and MIS-C in the Brazilian Amazon.
- To identify factors associated with in-hospital mortality in this vulnerable pediatric population.
Main Methods:
- A multicenter prospective cohort study included 266 critically ill children (1 month to 18 years) with COVID-19/MIS-C.
- In-hospital mortality was the primary outcome, analyzed using multivariable Cox regression, adjusted for PRISMIV score, age, and comorbidities.
- Data were collected from three tertiary Pediatric Intensive Care Units (PICUs) between April 2020 and May 2023.
Main Results:
- Overall mortality was high, with 22.5% in the severe COVID-19 group and 21.5% in the MIS-C group.
- Mortality was significantly associated with higher Vasoactive Inotropic Score (VIS), acute respiratory distress syndrome (ARDS), elevated Erythrocyte Sedimentation Rate (ESR), and thrombocytopenia.
- The median time to death was within 12 days of hospitalization for both severe COVID-19 and MIS-C patients.
Conclusions:
- Critically ill children with severe COVID-19 and MIS-C in the Brazilian Amazon face a substantial risk of in-hospital mortality.
- Prompt recognition and management of complications such as ARDS and coagulopathies are crucial for improving outcomes.
Abstract:
SARS-CoV-2 infection in children is usually asymptomatic/mild. However, some patients may develop critical forms. We aimed to describe characteristics and evaluate the factors associated to in-hospital mortality of patients with critical COVID-19/MIS-C in the Amazonian region. This multicenter prospective cohort included critically ill children (1 mo-18 years old), with confirmed COVID-19/MIS-C admitted to 3 tertiary Pediatric Intensive Care Units (PICU) in the Brazilian Amazon, between April/2020 and May/2023. The main outcome was in-hospital mortality and were evaluated using a multivariable Cox proportional regression. We adjusted the model for pediatric risk of mortality score version IV (PRISMIV) score and age/comorbidity. 266 patients were assessed with 187 in the severe COVID-19 group, 79 included in the MIS-C group. In the severe COVID-19 group 108 (57.8%) were male, median age was 23 months, 95 (50.8%) were up to 2 years of age. Forty-two (22.5%) patients in this group died during follow-up in a median time of 11 days (IQR, 2-28). In the MIS-C group, 56 (70.9%) were male, median age was 23 months and median follow-up was 162 days (range, 3-202). Death occurred in 17 (21.5%) patients with a median death time of 7 (IQR, 4-13) days. The mortality was associated with higher levels of Vasoactive Inotropic-Score (VIS), presence of acute respiratory distress syndrome (ARDS), higher levels of Erythrocyte Sedimentation Rate, (ESR) and thrombocytopenia. Critically ill patients with severe COVID-19 and MIS-C from the Brazilian Amazon showed a high mortality rate, within 12 days of hospitalization.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...